149 related articles for article (PubMed ID: 3091928)
21. Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome.
Rector WG; Kanel GC; Rakela J; Reynolds TB
Hepatology; 1985; 5(2):321-6. PubMed ID: 3884478
[TBL] [Abstract][Full Text] [Related]
22. Hereditary tyrosinaemia type I: a long-term study of the relationship between the urinary excretions of succinylacetone and delta-aminolevulinic acid.
Schierbeek H; Beukeveld GJ; van Faassen H; van Spronsen FJ; Bijsterveld K; Venekamp-Hoolsema EE; Wolthers BG; Smit GP
J Inherit Metab Dis; 1993; 16(6):1034-40. PubMed ID: 8127053
[TBL] [Abstract][Full Text] [Related]
23. Neurological crisis in hereditary tyrosinaemia and complete reversal after liver transplantation.
Noble-Jamieson G; Jamieson N; Clayton P; Bailey S; Ryalls M; Barnes ND
Arch Dis Child; 1994 Jun; 70(6):544-5. PubMed ID: 8048831
[TBL] [Abstract][Full Text] [Related]
24. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.
Tuchman M; Freese DK; Sharp HL; Ramnaraine ML; Ascher N; Bloomer JR
J Pediatr; 1987 Mar; 110(3):399-403. PubMed ID: 3546650
[TBL] [Abstract][Full Text] [Related]
25. Hepatic imaging with computed tomography of chronic tyrosinaemia type 1.
Macvicar D; Dicks-Mireaux C; Leonard JV; Wight DG
Br J Radiol; 1990 Aug; 63(752):605-8. PubMed ID: 2400875
[TBL] [Abstract][Full Text] [Related]
26. Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
Kvittingen EA; Leonard JV; Pettit BR; King GS
Clin Chim Acta; 1985 Nov; 152(3):271-9. PubMed ID: 4064334
[TBL] [Abstract][Full Text] [Related]
27. Tyrosinemia: the Quebec experience.
Paradis K
Clin Invest Med; 1996 Oct; 19(5):311-6. PubMed ID: 8889268
[TBL] [Abstract][Full Text] [Related]
28. Hereditary tyrosinemia type I--an overview.
Kvittingen EA
Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
[TBL] [Abstract][Full Text] [Related]
29. STUDIES ON TYROSINOSIS: 1, EFFECT OF LOW-TYROSINE AND LOW-PHENYLALANINE DIET.
HALVORSEN S; GJESSING LR
Br Med J; 1964 Nov; 2(5418):1171-3. PubMed ID: 14190487
[No Abstract] [Full Text] [Related]
30. Tyrosinaemia type I--an update.
Kvittingen EA
J Inherit Metab Dis; 1991; 14(4):554-62. PubMed ID: 1749221
[TBL] [Abstract][Full Text] [Related]
31. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.
Ho PT; Zimmerman K; Wexler LH; Blaney S; Jarosinski P; Weaver-McClure L; Izraeli S; Balis FM
Cancer; 1995 Dec; 76(12):2557-64. PubMed ID: 8625085
[TBL] [Abstract][Full Text] [Related]
32. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
Sassa S; Kappas A
Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
[TBL] [Abstract][Full Text] [Related]
33. Nephropathy of tyrosinemia and its long-term outlook.
Paradis K; D'Angata ID
J Pediatr Gastroenterol Nutr; 1997 Jan; 24(1):113-4. PubMed ID: 9093996
[No Abstract] [Full Text] [Related]
34. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
Berger R; Smit GP; Stoker-de Vries SA; Duran M; Ketting D; Wadman SK
Clin Chim Acta; 1981 Jul; 114(1):37-44. PubMed ID: 7249373
[TBL] [Abstract][Full Text] [Related]
35. On rat renal aminolevulinate transport and metabolism in experimental Fanconi syndrome.
Roth KS; Carter BE; Moses LC; Spencer PD
Biochem Med Metab Biol; 1990 Dec; 44(3):238-46. PubMed ID: 2288767
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein.
Peterson PA; Evrin PE; Berggård I
J Clin Invest; 1969 Jul; 48(7):1189-98. PubMed ID: 4978446
[TBL] [Abstract][Full Text] [Related]
37. Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.
Poudrier J; Lettre F; St-Louis M; Tanguay RM
Prenat Diagn; 1999 Jan; 19(1):61-3. PubMed ID: 10073910
[TBL] [Abstract][Full Text] [Related]
38. Hereditary tyrosinaemia. Clinical, enzymatic, and pathological study of an infant with the acute form of the disease.
Carson NA; Biggart JD; Bittles AH; Donovan D
Arch Dis Child; 1976 Feb; 51(2):106-13. PubMed ID: 1259456
[TBL] [Abstract][Full Text] [Related]
39. Succinylacetone and delta-aminolevulinic acid dehydratase in hereditary tyrosinemia: immunochemical study of the enzyme.
Sassa S; Fujita H; Kappas A
Pediatrics; 1990 Jul; 86(1):84-6. PubMed ID: 2359685
[TBL] [Abstract][Full Text] [Related]
40. [Experimental studies in a case of tyrosinosis. New pathogenic hypothesis].
Lissitzky S; Laurent B; Bernard P; Fenasse R
Rev Fr Etud Clin Biol; 1969 Jan; 14(1):19-30. PubMed ID: 5784817
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
